Recombinant Human PD-L1 Protein (HEK293, C-Fc)  别名:Programmed Cell Death 1 Ligand 1; B7 Homolog 1; 重组人PD-L1 蛋白 (HEK293, C-Fc)

目录号 M58710

PD-L1 (also known as CD274, B7-H1) is a 40 kD type I transmembrane protein and a member of the B7 family within the immunoglobulin receptor superfamily. By binding to PD1 on activated T-cells and B-cells, PD-L1 may inhibit ongoing T-cell responses by inducing apoptosis and arresting cell-cycle progression.

Recombinant Human PD-L1 Protein (HEK293, C-Fc)结构式

 

规格 价格 库存状态
10ug ¥ 920 现货
50ug ¥ 2400 现货
本产品不参加促销活动    
*AbMole所有产品仅供有资质的科研机构或医药企业进行科学研究或药证申报用途,不能被用于人体和任何其它用途。我们不向任何个人或非科研性质的机构提供产品和服务。
质量标准及产品资料
  • 纯度:>95%, Endotoxin < 1 EU/µg
  • COA
化学性质/溶解性/储存
性状 Lyophilized powder
中文名称 重组人PD-L1 蛋白 (HEK293, C-Fc);程序性死亡配体 1
溶解性 Reconstitute the lyophilized powder in distilled water to a concentration not less than 100 μg/mL.
储存条件 Stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days and at -20°C for 3 months.
运输方式 冰袋运输,根据产品的不同,可能会有相应调整。
生物活性

PD-L1 (also known as CD274, B7-H1) is a 40 kD type I transmembrane protein and a member of the B7 family within the immunoglobulin receptor superfamily. By binding to PD1 on activated T-cells and B-cells, PD-L1 may inhibit ongoing T-cell responses by inducing apoptosis and arresting cell-cycle progression. Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance.

Recombinant Human PD-L1 expressed the target gene encoding Phe19-Thr239 with a human IgG1 Fc tag at the C-terminus.

Immobilized Human PD-L1 at 2μg/ml (100 μl/well) can bind Anti-Human PDL1 mAb-Fc, the ED50 of Anti-Human PDL1 mAb-Fc is 8.41 ng/ml.


Accession: Q9NZQ7

Apparent Molecular Weight: 70-80 KDa, under reducing conditions

Endotoxin < 1 EU/µg

Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

实验参考
动物实验

建议您制定动物给药及实验方案时,尽量参考已发表的相关实验文献(溶剂种类及配比众多,简单地溶解目的化合物,并不能解决动物给药依从性、体内生物利用度、组织分布等相关问题,未必能保证目的化合物在动物体内充分发挥生物学效用)。
体内实验的工作液,建议您现用现配,当天使用;如在配制过程中出现沉淀、析出现象,可以通过超声和(或)加热的方式助溶。
切勿一次性将产品全部溶解。


动物实验方案计算器

请在下面的计算器中,输入您的动物实验相关数据并点击计算,即可得到该实验的总需药量和工作液终浓度。
例如您给药剂量是10 mg/kg,平均每只动物的体重为20 g,每只动物的给药体积是100 μL,动物数量为20只,则该动物实验的总需药量为4 mg,工作液终浓度为2 mg/mL。

mg/kg
uL
该动物实验的总需药量为 mg
工作液终浓度2 mg/mL

1:鉴于实验过程的损耗,建议您至少多配1-2只动物的量;
2:为该产品最终给药时的浓度。

其他相关的Immune Checkpoint Proteins产品





关键词:Recombinant Human PD-L1 Protein (HEK293, C-Fc), Programmed Cell Death 1 Ligand 1; B7 Homolog 1, Recombinant Human PD-L1 Protein (HEK293, C-Fc)供应商, Immune Checkpoint Proteins抑制剂, 购买Recombinant Human PD-L1 Protein (HEK293, C-Fc), Recombinant Human PD-L1 Protein (HEK293, C-Fc)溶解度, Recombinant Human PD-L1 Protein (HEK293, C-Fc)结构式







产品仅供科学研究或药证申报的用途使用,不为任何个人或者非科研性质的其他用途提供服务。

Copyright © 2010-2025 AbMole版权所有